Hormonal Therapy Brings About Facial Changes in Transgender Individuals
Peyronie's Disease: Study Examines CCH / RestoreX Traction Combination Therapy
Transmen and transwomen may start noticing changes in their facial features during their first year of hormone therapy, according to new research in the Journal of Sexual Medicine.
Using 3-dimensional imaging technology, the researchers monitored facial changes in a group of transmen and transwomen over the course of a year.
The most prominent changes were in cheek and jaw features, which were more in line with desired masculinization or feminization effects.
More specifics on the study, including information on the patients' facial satisfaction and self-esteem, can be found here.
Follow the ISSM on Instagram!
Intralesional injections of Clostridium histolyticum (CCH) are an effective treatment for Peyronie's disease. In some cases, injections are paired with traction therapy.
The RestoreX traction device is a more recently developed therapy that has had encouraging results in clinical trials.
How do patients fare when undergoing CCH and RestoreX traction together? And how does this combination compare with other approaches? These questions were recently addressed in a Journal of Sexual Medicine study, which is the subject of our website's latest research summary.
Click here to learn more.
You might already follow the ISSM on LinkedIn, Facebook, and Twitter. But did you know we're on Instagram, too?
Instagram is different from other social media platforms. It's more mobile- and image-based, making message delivery fast and fun.
Check out our latest posts here!